Lifecore Biomedical, Inc. LFCR Reportable Segment — Interest Income (Expense), Nonoperating
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s reportable segment — interest income (expense), nonoperating.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s reportable segment — interest income (expense), nonoperating?
- Lifecore Biomedical, Inc. (LFCR) reported reportable segment — interest income (expense), nonoperating of -$7.22M in Q1 2026.
- What does reportable segment — interest income (expense), nonoperating mean?
- This metric represents the net cost of financing or the income earned from cash balances and investments outside of core operations. It reflects the segment's reliance on debt capital and the impact of interest rate environments on the bottom line.